INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
May 12, 2020 |
Director, President & CEO
Trans History: 404
|
Director, President & CEO | Form 4 | Open market or private sale of non-derivative or derivative security | 19,984 | $572.47 | 493,465 |
May 20, 2020 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 77,309 | $30.63 | 497,063 |
Mar 11, 2020 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 500,000 |
Feb 25, 2020 |
Director, President and Chief Scientific
Trans History: 628
|
Director, President and Chief Scientific | Form 4 | Other acquisition or disposition | -- | -- | 500,000 |
Jun 13, 2019 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 500,000 | -- | 500,000 |
Feb 10, 2017 |
Director, President & CSO
Trans History: 628
|
Director, President & CSO | Form 5 | Other acquisition or disposition | -- | -- | 500,000 |
Dec 16, 2016 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 89,427 | -- | 500,000 |
Jul 21, 2016 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Bona fide gift | 500,000 | -- | 500,000 |
Dec 17, 2015 |
Director, President and CSO
Trans History: 628
|
Director, President and CSO | Form 4 | Bona fide gift | 1,921 | -- | 500,000 |
Dec 02, 2015 |
Director, President Regeneron Laboratori
Trans History: 628
|
Director, President Regeneron Laboratori | Form 4 | Open market or private sale of non-derivative or derivative security | 1,900 | $555.26 | 500,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.